IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Oral Dispersible Film Containing Eletriptan Hydrobromide for Treatment of Migraine: Design, Formulation, Evaluation and Optimization

Author: SWAPNIL PALVE, RAJENDRA MOGAL, NAYAN GUJARATHI, ANIL JADHAV
Abstract: The objective of present work was to develop rapidly orally dispersing film of eletriptan hydrobromide for treatment of migraine headache. The excipients used for preparation of rapidly orally dispersing film were screened for compatibility with the help of Differential Scanning Calorimetry (DSC) and Oral Dispersible Film (ODF) was fabricated by solvent casting method using compatible excipients. DSC thermograms do not shown significant change in endothermic behavior, which indicated all excipients were compatible with the drug.ODF prepared with Hydroxylpropyl Methylcellulose (HPMC) E-15 was transparent, non-tacky, flexible, disintegrate within specified time, with good tensile strength. The fabricated film was evaluated for disintegration time, dissolution profile, folding endurance, tensile strength, surface pH, thickness etc. 32 full factorial design was used for optimization of ODF by selecting concentration of PG (X1) and concentration of HPMC E-15 (X2) as an independent variables and disintegration time (Y1) as a dependent variable. The optimized ODF disintegrate within 25.65 sec and around 90% drug content. Prepared ODF rapidly disintegrate which indicate fast therapeutic effect which required in acute attack of migraine.
Keyword: Eletriptan hydrobromide, Oral Dispersible Film, Migraine, Optimization, Tensile Strength
DOI: https://doi.org/10.31838/ijpr/2019.11.04.054
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free